# Franklin Covey Co: financial statements, quarterly

FC · NYSE · CIK 886206 · [Industrials](/sectors/industrials.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/fc.md) · [Financials](/companies/fc/financials.md) · [Filings](/companies/fc/filings.md) · [Insiders](/companies/fc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [78.0 d](/filings/0000886206-25-000085.md) | [68.4](/filings/0000886206-25-000004.md) | [61.3](/filings/0000886206-25-000036.md) | [73.4](/filings/0000886206-25-000048.md) | [84.1 d](/filings/0000886206-25-000085.md) | [69.1](/filings/0001193125-26-008932.md) | [59.6](/filings/0001193125-26-147784.md) | [67.1](/filings/0001193125-26-297572.md) | [71.2 d](/filings/0000886206-25-000085.md) | [64.0](/filings/0001193125-26-008932.md) | [59.6](/filings/0001193125-26-147784.md) | [67.8](/filings/0001193125-26-297572.md) |
| Cost of revenue | $m | [18.7 d](/filings/0000886206-25-000085.md) | [16.1](/filings/0000886206-25-000004.md) | [14.5](/filings/0000886206-25-000036.md) | [17.2](/filings/0000886206-25-000048.md) | [18.4 d](/filings/0000886206-25-000085.md) | [16.4](/filings/0001193125-26-008932.md) | [13.9](/filings/0001193125-26-147784.md) | [15.8](/filings/0001193125-26-297572.md) | [17.5 d](/filings/0000886206-25-000085.md) | [15.7](/filings/0001193125-26-008932.md) | [14.4](/filings/0001193125-26-147784.md) | [17.7](/filings/0001193125-26-297572.md) |
| Gross profit | $m | [59.3 d](/filings/0000886206-25-000085.md) | [52.3](/filings/0000886206-25-000004.md) | [46.9](/filings/0000886206-25-000036.md) | [56.2](/filings/0000886206-25-000048.md) | [65.7 d](/filings/0000886206-25-000085.md) | [52.7](/filings/0001193125-26-008932.md) | [45.7](/filings/0001193125-26-147784.md) | [51.3](/filings/0001193125-26-297572.md) | [53.8 d](/filings/0000886206-25-000085.md) | [48.4](/filings/0001193125-26-008932.md) | [45.3](/filings/0001193125-26-147784.md) | [50.1](/filings/0001193125-26-297572.md) |
| Selling, general and administrative | $m | [46.0 d](/filings/0000886206-25-000085.md) | [44.2](/filings/0000886206-25-000004.md) | [40.8](/filings/0000886206-25-000036.md) | [45.1](/filings/0000886206-25-000048.md) | [45.9 d](/filings/0000886206-25-000085.md) | [47.2](/filings/0001193125-26-008932.md) | [45.1](/filings/0001193125-26-147784.md) | [46.2](/filings/0001193125-26-297572.md) | [44.2 d](/filings/0000886206-25-000085.md) | [46.1](/filings/0001193125-26-008932.md) | [43.5](/filings/0001193125-26-147784.md) | [43.3](/filings/0001193125-26-297572.md) |
| Operating income | $m | [10.6 d](/filings/0000886206-25-000085.md) | [5.3](/filings/0000886206-25-000004.md) | [1.4](/filings/0000886206-25-000036.md) | [8.3](/filings/0000886206-25-000048.md) | [17.9 d](/filings/0000886206-25-000085.md) | [1.5](/filings/0001193125-26-008932.md) | [(1.5)](/filings/0001193125-26-147784.md) | [(2.2)](/filings/0001193125-26-297572.md) | [7.9 d](/filings/0000886206-25-000085.md) | [(3.7)](/filings/0001193125-26-008932.md) | [(2.0)](/filings/0001193125-26-147784.md) | [4.2](/filings/0001193125-26-297572.md) |
| Interest expense | $m | [0.4 d](/filings/0000886206-25-000085.md) | [0.3](/filings/0000886206-25-000004.md) | [0.3](/filings/0000886206-25-000036.md) | [0.2](/filings/0000886206-25-000048.md) | [0.2 d](/filings/0000886206-25-000085.md) | [0.2](/filings/0001193125-26-008932.md) | [0.2](/filings/0001193125-26-147784.md) | [0.1](/filings/0001193125-26-297572.md) | [0.1 d](/filings/0000886206-25-000085.md) | [0.1](/filings/0001193125-26-008932.md) | [0.1](/filings/0001193125-26-147784.md) | [0.1](/filings/0001193125-26-297572.md) |
| Income tax | $m | [3.6 d](/filings/0000886206-25-000085.md) | [0.4](/filings/0000886206-25-000004.md) | [0.5](/filings/0000886206-25-000036.md) | [2.6](/filings/0000886206-25-000048.md) | [6.0 d](/filings/0000886206-25-000085.md) | [0.4](/filings/0001193125-26-008932.md) | [(0.3)](/filings/0001193125-26-147784.md) | [(0.7)](/filings/0001193125-26-297572.md) | [3.6 d](/filings/0000886206-25-000085.md) | [(0.3)](/filings/0001193125-26-008932.md) | [(0.1)](/filings/0001193125-26-147784.md) | [1.1](/filings/0001193125-26-297572.md) |
| Net income | $m | [6.8 d](/filings/0000886206-25-000085.md) | [4.9](/filings/0000886206-25-000004.md) | [0.9](/filings/0000886206-25-000036.md) | [5.7](/filings/0000886206-25-000048.md) | [12.0 d](/filings/0000886206-25-000085.md) | [1.2](/filings/0001193125-26-008932.md) | [(1.1)](/filings/0001193125-26-147784.md) | [(1.4)](/filings/0001193125-26-297572.md) | [4.4 d](/filings/0000886206-25-000085.md) | [(3.3)](/filings/0001193125-26-008932.md) | [(2.0)](/filings/0001193125-26-147784.md) | [3.1](/filings/0001193125-26-297572.md) |
| Diluted EPS | $ per share | not reported | [0.36](/filings/0000886206-25-000004.md) | [0.06](/filings/0000886206-25-000036.md) | [0.43](/filings/0000886206-25-000048.md) | not reported | [0.09](/filings/0001193125-26-008932.md) | [(0.08)](/filings/0001193125-26-147784.md) | [(0.11)](/filings/0001193125-26-297572.md) | not reported | [(0.27)](/filings/0001193125-26-008932.md) | [(0.17)](/filings/0001193125-26-147784.md) | [0.27](/filings/0001193125-26-297572.md) |
| Basic EPS | $ per share | not reported | [0.37](/filings/0000886206-25-000004.md) | [0.07](/filings/0000886206-25-000036.md) | [0.43](/filings/0000886206-25-000048.md) | not reported | [0.09](/filings/0001193125-26-008932.md) | [(0.08)](/filings/0001193125-26-147784.md) | [(0.11)](/filings/0001193125-26-297572.md) | not reported | [(0.27)](/filings/0001193125-26-008932.md) | [(0.17)](/filings/0001193125-26-147784.md) | [0.27](/filings/0001193125-26-297572.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [38.2](/filings/0000886206-24-000060.md) | [34.0](/filings/0000886206-24-000005.md) | [40.9](/filings/0000886206-24-000028.md) | [36.6](/filings/0000886206-24-000040.md) | [48.7](/filings/0000886206-25-000085.md) | [53.3](/filings/0000886206-25-000004.md) | [40.4](/filings/0000886206-25-000036.md) | [33.7](/filings/0000886206-25-000048.md) | [31.7](/filings/0001193125-26-297572.md) | [17.5](/filings/0001193125-26-008932.md) | [13.7](/filings/0001193125-26-147784.md) | [12.0](/filings/0001193125-26-297572.md) |
| Current assets | $m | [145](/filings/0000886206-24-000060.md) | [117](/filings/0000886206-24-000005.md) | [122](/filings/0000886206-24-000028.md) | [120](/filings/0000886206-24-000040.md) | [160](/filings/0000886206-25-000085.md) | [139](/filings/0000886206-25-000004.md) | [121](/filings/0000886206-25-000036.md) | [111](/filings/0000886206-25-000048.md) | [129](/filings/0001193125-26-297572.md) | [109](/filings/0001193125-26-008932.md) | [95.4](/filings/0001193125-26-147784.md) | [91.8](/filings/0001193125-26-297572.md) |
| Total assets | $m | [246](/filings/0000886206-24-000060.md) | [219](/filings/0000886206-24-000005.md) | [222](/filings/0000886206-24-000028.md) | [221](/filings/0000886206-24-000040.md) | [262](/filings/0000886206-25-000085.md) | [240](/filings/0000886206-25-000004.md) | [221](/filings/0000886206-25-000036.md) | [218](/filings/0000886206-25-000048.md) | [243](/filings/0001193125-26-297572.md) | [221](/filings/0001193125-26-008932.md) | [206](/filings/0001193125-26-147784.md) | [198](/filings/0001193125-26-297572.md) |
| Current liabilities | $m | [152](/filings/0000886206-24-000060.md) | [135](/filings/0000886206-24-000005.md) | [138](/filings/0000886206-24-000028.md) | [137](/filings/0000886206-24-000040.md) | [162](/filings/0000886206-25-000085.md) | [144](/filings/0000886206-25-000004.md) | [134](/filings/0000886206-25-000036.md) | [132](/filings/0000886206-25-000048.md) | [157](/filings/0001193125-26-297572.md) | [149](/filings/0001193125-26-008932.md) | [152](/filings/0001193125-26-147784.md) | [140](/filings/0001193125-26-297572.md) |
| Total liabilities | $m | [167](/filings/0000886206-24-000060.md) | [148](/filings/0000886206-24-000005.md) | [151](/filings/0000886206-24-000028.md) | [149](/filings/0000886206-24-000040.md) | [178](/filings/0000886206-25-000085.md) | [159](/filings/0000886206-25-000004.md) | [149](/filings/0000886206-25-000036.md) | [153](/filings/0000886206-25-000048.md) | [176](/filings/0001193125-26-297572.md) | [167](/filings/0001193125-26-008932.md) | [168](/filings/0001193125-26-147784.md) | [155](/filings/0001193125-26-297572.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [78.7](/filings/0000886206-24-000060.md) | [70.5](/filings/0000886206-24-000005.md) | [70.8](/filings/0000886206-24-000028.md) | [72.2](/filings/0000886206-24-000040.md) | [83.1](/filings/0000886206-25-000085.md) | [80.6](/filings/0000886206-25-000004.md) | [72.5](/filings/0000886206-25-000036.md) | [65.6](/filings/0000886206-25-000048.md) | [66.9](/filings/0001193125-26-297572.md) | [54.0](/filings/0001193125-26-008932.md) | [38.1](/filings/0001193125-26-147784.md) | [42.9](/filings/0001193125-26-297572.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [9.8 d](/filings/0000886206-25-000085.md) | [17.4](/filings/0000886206-25-000004.md) | [12.8 d](/filings/0000886206-25-000036.md) | [8.2 d](/filings/0000886206-25-000048.md) | [21.9 d](/filings/0000886206-25-000085.md) | [14.1](/filings/0001193125-26-008932.md) | [(1.4) d](/filings/0001193125-26-147784.md) | [6.3 d](/filings/0001193125-26-297572.md) | [9.9 d](/filings/0000886206-25-000085.md) | [0.1](/filings/0001193125-26-008932.md) | [16.3 d](/filings/0001193125-26-147784.md) | [1.1 d](/filings/0001193125-26-297572.md) |
| Capital expenditure | $m | [1.0 d](/filings/0000886206-25-000085.md) | [1.1](/filings/0000886206-25-000004.md) | [0.6 d](/filings/0000886206-25-000036.md) | [0.9 d](/filings/0000886206-25-000048.md) | [1.1 d](/filings/0000886206-25-000085.md) | [1.0](/filings/0001193125-26-008932.md) | [1.3 d](/filings/0001193125-26-147784.md) | [1.8 d](/filings/0001193125-26-297572.md) | [4.2 d](/filings/0000886206-25-000085.md) | [1.7](/filings/0001193125-26-008932.md) | [1.0 d](/filings/0001193125-26-147784.md) | [1.2 d](/filings/0001193125-26-297572.md) |
| Share repurchases | $m | [5.9 d](/filings/0000886206-25-000085.md) | [16.3](/filings/0000886206-25-000004.md) | [2.1 d](/filings/0000886206-25-000036.md) | [7.4 d](/filings/0000886206-25-000048.md) | [4.9 d](/filings/0000886206-25-000085.md) | [6.0](/filings/0001193125-26-008932.md) | [8.7 d](/filings/0001193125-26-147784.md) | [8.3 d](/filings/0001193125-26-297572.md) | [3.4 d](/filings/0000886206-25-000085.md) | [10.7](/filings/0001193125-26-008932.md) | [17.4 d](/filings/0001193125-26-147784.md) | [0.0 d](/filings/0001193125-26-297572.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-30) | Q2 FY2023 (2023-02-28) | Q3 FY2023 (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.5](/filings/0000886206-24-000005.md) | [14.5](/filings/0000886206-24-000028.md) | [14.3](/filings/0000886206-24-000040.md) | [13.6](/filings/0000886206-25-000004.md) | [13.5](/filings/0000886206-25-000036.md) | [13.4](/filings/0000886206-25-000048.md) | [13.3](/filings/0001193125-26-008932.md) | [13.1](/filings/0001193125-26-147784.md) | [12.9](/filings/0001193125-26-297572.md) | [12.2](/filings/0001193125-26-008932.md) | [11.4](/filings/0001193125-26-147784.md) | [11.5](/filings/0001193125-26-297572.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,293,873 at 2026-06-30, from the cover of the [10-Q filed 2026-07-07](/filings/0001193125-26-297572.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.